JCB, Volume 24, Number 4, 2019 Article Vol.24 No. 4 (2019) Transforming Technology Into High-Value Solutions for Compelling Biomedical Needs: Bio Entrepreneurship Bootcamp 2.0 Arthur Boni Startups are an important source of innovation for any industry, particularly for disruptive or transformative innovations enabled by technology. Therefore, it is no surprise that the sta Article Vol.24 No. 4 (2019) Evolution of the Screening Metaphor: Project, Product, or Platform? Arthur Boni There are multiple options or paths to the market to be considered when developing the commercialization strategy for translating a technology or invention into an innovation. We present Article Vol.24 No. 4 (2019) Aligning the Corporation for Transformative Innovation: Introducing Innovation Dashboard 2.0 Arthur Boni Under pressure from mounting forces of change, corporations must engage in innovation more than ever. The transformative types of innovation required for organizations to thrive in the lo Article Vol.24 No. 4 (2019) Four Models for Corporate Transformative, Open Innovation Arthur Boni Four models are identified for organizations to pursue simultaneous core growth and transformative innovation leveraging open innovation principles: 1) corporate accelerators — Article Vol.24 No. 4 (2019) IP Fundamentals – What Every CEO Should Know About IP in Biotechnology Kathryn Doyle This chapter addresses four essential components of Intellectual Property as it relates to patents: (1) patents and the patent process, (2) developing a strategy to maximize patent protec Article Vol.24 No. 4 (2019) Intellectual Property for Life Science Entrepreneurs Raymond Miller This article provides an overview of the various forms of intellectual property that are available for life science entrepreneurs. These include patent, trademarks, trade secrets, and Article Vol.24 No. 4 (2019) Intellectual Property – Solidify Your Competitive Edge James Jordan This article notes that startup companies are temporary organizations in search of a repeatable and scalable business model that provides the organization with the ability to scale and gr Article Vol.24 No. 4 (2019) 2018 Mostly a Sideways Market Masking a Lot of Excitement: Innovation and Science Keep the Party Rolling Edwin Gordon Building science and technology-based organizations requires a reliable and steady stream of funding across the life cycle of the company. Along with building a good team, building a netw Article Vol.24 No. 4 (2019) Founding and Funding a Life Sciences Company: An Overview James Jordan Founding and funding a company demands that the founding team and their advisors identify and articulate the myriad of challenges and risks that they will face in pursuit of their vision. Article Vol.24 No. 4 (2019) Strategic Planning for Financing and Growing Biotechnology Companies Claudine Kearney There are significant aspirations from both start-ups an Article Vol.24 No. 4 (2019) “The Good, the Bad, the Ugly”: Leadership Lessons From two Companies – Amgen and Theranos Arthur Boni We review two books that provide perspective on leadership challenges and best practices for building successful companies. Lessons and frameworks are extracted from our reviews of recent Article Vol.24 No. 4 (2019) Leading and Managing Teams in Entrepreneurial Organizations: an Experiential Perspective Arthur Boni This article focuses on summarizing best practices for leading and managing diverse teams in entrepreneurial companies. Our approach is to build on sound academic principles, but we focus Article Vol.24 No. 4 (2019) Building and Managing Great Teams: An Evidence-Based Approach Gergana Todorova Efforts to initiate new startups rely heavily on teams and networks. R Article Vol.24 No. 4 (2019) Setting Up and Working with a Board of Directors: A Guide for Startups James Jordan Commercializing the idea behind the next big thing is only the first step on a long road to success for a company founder. Facing a myriad of regulatory obstacles, funding challenges, and Article Vol.24 No. 4 (2019) When an FDA Drug Approval Makes Mainstream News: The Announcement of Zulresso, A Media Case Study Moira Gunn Media coverage following U.S. Food and Drug Administration (FDA) drug approvals is generally found in two sectors: bioindustry news and the financial markets. The March 19, 2019 FDA annou Article Vol.24 No. 4 (2019) The Complexity of Pharmaceutical Prices: An Economic Analysis Erwin Blackstone This article examines the complexity of pharmaceutical pricing. Specifically, list prices are often considerably higher than net prices. PBMs have considerable market power to obtain subs Article Vol.24 No. 4 (2019) The R&D Marketing Interface in Biopharma and MedTech Thani Jambulingam This article highlights the importance of building a marketing led cross-functional team that integrates the R&D, and commercialization process in an early stage Biopharma and MedTech
